{"id":14881,"date":"2026-05-29T06:00:00","date_gmt":"2026-05-29T10:00:00","guid":{"rendered":"https:\/\/cov19longhaulfoundation.org\/?p=14881"},"modified":"2026-05-16T10:09:56","modified_gmt":"2026-05-16T14:09:56","slug":"covid-19-and-hair-follicle-biology","status":"publish","type":"post","link":"https:\/\/cov19longhaulfoundation.org\/?p=14881","title":{"rendered":"COVID-19 and Hair Follicle Biology"},"content":{"rendered":"\n<h2 class=\"wp-block-heading has-regular-font-size\">A Comprehensive Review of Etiology, Physiology, Pathology, Proteomics, and Therapeutic Approaches<\/h2>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">1. Abstract<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">COVID-19, caused by SARS-CoV-2, is associated with a broad spectrum of post-infectious dermatologic sequelae, most prominently diffuse hair loss in the form of telogen effluvium (TE). Hair follicle dysfunction appears to arise from a convergence of systemic inflammatory activation, cytokine-mediated follicular cycling disruption, vascular endothelial injury, hypoxic stress, and metabolic reprogramming of follicular keratinocytes. Emerging evidence also suggests potential viral-associated molecular effects on follicular epithelium and immune privilege collapse within the hair bulb microenvironment. This review synthesizes current evidence on pathophysiology, protein-level alterations, clinical phenotypes, diagnostic approaches, and therapeutic strategies for COVID-19\u2013associated hair disorders, with emphasis on long COVID presentations and persistent alopecia syndromes.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">2. Introduction: The Hair Follicle as a Systemic Stress Sensor<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The hair follicle is a highly dynamic neuroectodermal-mesenchymal organ characterized by cyclical regeneration. It is uniquely sensitive to systemic perturbations due to its high proliferative rate and dependence on tightly regulated signaling pathways.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In systemic illness, the follicle acts as a \u201cbiological recorder,\u201d translating metabolic, inflammatory, and vascular stress into delayed structural changes in the hair shaft.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">COVID-19 represents a prototypical systemic inflammatory disease capable of disrupting multiple regulatory axes simultaneously, making it particularly prone to inducing diffuse hair shedding.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">3. Epidemiology of Post-COVID Hair Loss<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Multiple cohort studies report:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>20\u201335% of post-COVID patients experience noticeable hair shedding<\/li>\n\n\n\n<li>Women are disproportionately affected (female:male ratio ~3:1)<\/li>\n\n\n\n<li>Median onset occurs 6\u201312 weeks after acute infection\u00b9<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Severity correlates with:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>hospitalization status<\/li>\n\n\n\n<li>fever duration<\/li>\n\n\n\n<li>inflammatory marker elevation<\/li>\n\n\n\n<li>psychological stress burden<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">4. Hair Cycle Disruption in COVID-19<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">4.1 Anagen-to-telogen shift<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The dominant mechanism in COVID-19\u2013associated alopecia is premature termination of anagen phase, leading to synchronized entry into telogen.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This is mediated by:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>inflammatory cytokines<\/li>\n\n\n\n<li>metabolic stress<\/li>\n\n\n\n<li>vascular dysfunction<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">4.2 Catagen acceleration<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">TGF-\u03b2 signaling is upregulated during systemic illness, accelerating apoptosis of matrix keratinocytes and promoting regression phase entry.\u00b2<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">4.3 Follicular stem cell quiescence<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Bulge stem cells may enter prolonged quiescence due to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>inflammatory suppression<\/li>\n\n\n\n<li>Wnt\/\u03b2-catenin pathway inhibition<\/li>\n\n\n\n<li>energy depletion<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">5. Inflammatory Pathophysiology<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">COVID-19\u2013associated cytokine profiles play a central role in follicular disruption.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Key mediators:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">IL-6<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>inhibits keratinocyte proliferation<\/li>\n\n\n\n<li>disrupts anagen maintenance signaling\u00b3<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">TNF-\u03b1<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>induces follicular apoptosis<\/li>\n\n\n\n<li>promotes catagen transition<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">IFN-\u03b3<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>disrupts immune privilege of follicle<\/li>\n\n\n\n<li>enhances local immune infiltration<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">This cytokine milieu reproduces a \u201csystemic stress signal\u201d that follicles interpret as a cue to halt growth.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">6. Vascular and Endothelial Injury Mechanisms<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">SARS-CoV-2 induces systemic endothelial dysfunction, including:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>microthrombi formation<\/li>\n\n\n\n<li>impaired capillary perfusion<\/li>\n\n\n\n<li>inflammatory endotheliitis\u2074<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hair follicles are highly vascularized and dependent on dermal papilla perfusion.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Consequences include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>nutrient deprivation<\/li>\n\n\n\n<li>oxygen deficit<\/li>\n\n\n\n<li>follicular metabolic suppression<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">7. Hypoxia and Metabolic Reprogramming<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Hypoxemia during COVID-19 leads to activation of HIF-1\u03b1 signaling, resulting in:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>decreased mitochondrial ATP production<\/li>\n\n\n\n<li>impaired keratinocyte proliferation<\/li>\n\n\n\n<li>oxidative stress accumulation\u2075<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Even mild \u201csilent hypoxia\u201d can be sufficient to disrupt hair cycling.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">8. Molecular and Protein-Level Changes<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">COVID-19 induces measurable changes in follicular biology:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Structural proteins<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>decreased keratin K31 and K85 expression<\/li>\n\n\n\n<li>altered hair shaft tensile integrity<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Signaling pathways<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>suppression of Wnt\/\u03b2-catenin signaling<\/li>\n\n\n\n<li>upregulation of TGF-\u03b2 (catagen induction)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Stress proteins<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>increased heat shock proteins (HSP70, HSP90)<\/li>\n\n\n\n<li>elevated oxidative stress markers<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Immune proteins<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>increased MHC class I expression in follicular epithelium<\/li>\n\n\n\n<li>partial collapse of immune privilege zone\u2076<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">9. Clinical Phenotypes<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">9.1 Acute telogen effluvium<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>diffuse shedding<\/li>\n\n\n\n<li>onset 1\u20133 months post infection<\/li>\n\n\n\n<li>self-limited in majority<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">9.2 Chronic telogen effluvium<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>persists >6 months<\/li>\n\n\n\n<li>associated with long COVID<\/li>\n\n\n\n<li>fluctuating shedding patterns<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">9.3 Anagen effluvium (rare)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>seen in severe systemic illness<\/li>\n\n\n\n<li>rapid hair loss during acute phase<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">9.4 Unmasking of androgenetic alopecia<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>COVID-19 accelerates visible progression in predisposed individuals<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">10. Diagnosis<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Clinical diagnosis is primarily based on:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>temporal association with infection<\/li>\n\n\n\n<li>diffuse non-scarring alopecia<\/li>\n\n\n\n<li>positive hair pull test<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Laboratory evaluation may include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ferritin<\/li>\n\n\n\n<li>thyroid function<\/li>\n\n\n\n<li>vitamin D<\/li>\n\n\n\n<li>zinc levels<\/li>\n\n\n\n<li>CRP\/ESR<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Trichoscopy may show:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>empty follicles<\/li>\n\n\n\n<li>uniform hair shaft diameter reduction<\/li>\n\n\n\n<li>increased telogen hair ratio<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">11. Treatment Strategies<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">11.1 Supportive care<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>reassurance (critical in TE)<\/li>\n\n\n\n<li>nutritional optimization<\/li>\n\n\n\n<li>stress reduction<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">11.2 Pharmacologic approaches<\/h3>\n\n\n\n<h4 class=\"wp-block-heading\">Topical therapies<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>minoxidil (promotes anagen re-entry)<\/li>\n\n\n\n<li>anti-inflammatory scalp agents<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">Systemic therapies (selected cases)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>iron supplementation if deficient<\/li>\n\n\n\n<li>vitamin D correction<\/li>\n\n\n\n<li>anti-inflammatory modulation in long COVID (investigational)<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">11.3 Emerging therapies<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>JAK inhibitors (theoretical benefit in immune-mediated follicular dysfunction)<\/li>\n\n\n\n<li>mitochondrial support agents (experimental)<\/li>\n\n\n\n<li>autonomic regulation therapies in post-viral dysautonomia<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">12. Prognosis<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Most patients recover within 3\u20139 months. However:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>10\u201320% may develop prolonged shedding<\/li>\n\n\n\n<li>long COVID patients may experience cyclical recurrence<\/li>\n\n\n\n<li>psychological stress prolongs disease course<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">13. Integrated Pathophysiologic Model<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">COVID-19\u2013induced alopecia is best conceptualized as a <strong>multi-axis follicular stress syndrome<\/strong>:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>inflammatory cytokine suppression of anagen<\/li>\n\n\n\n<li>endothelial and microvascular dysfunction<\/li>\n\n\n\n<li>hypoxic metabolic arrest<\/li>\n\n\n\n<li>immune privilege collapse<\/li>\n\n\n\n<li>neuroendocrine stress amplification<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">These pathways converge to trigger synchronized telogen entry across large follicular populations.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">14. Clinical Implications<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Hair loss following COVID-19 serves as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>a marker of systemic inflammatory burden<\/li>\n\n\n\n<li>a delayed indicator of disease severity<\/li>\n\n\n\n<li>a potential feature of long COVID syndromes<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Recognition is important to avoid misdiagnosis as primary dermatologic disease.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">15. Limitations of Current Evidence<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>predominance of observational studies<\/li>\n\n\n\n<li>lack of follicular biopsy datasets in acute COVID-19<\/li>\n\n\n\n<li>confounding by psychological stress<\/li>\n\n\n\n<li>variability in reporting standards<\/li>\n\n\n\n<li>limited long-term cohort follow-up<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">16. Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">COVID-19 exerts profound effects on hair follicle biology through interconnected inflammatory, vascular, hypoxic, and metabolic pathways. The resulting condition, predominantly telogen effluvium, represents a systemic stress response rather than primary follicular disease. While prognosis is generally favorable, persistent cases highlight the role of long COVID in sustained follicular dysregulation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hair loss in COVID-19 should therefore be understood as a <strong>biological signal of systemic recovery status<\/strong>, integrating immune, vascular, and metabolic health.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">References <\/h1>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Malkud S. Telogen effluvium: a review. <em>J Clin Diagn Res.<\/em> 2015.<\/li>\n\n\n\n<li>Paus R, Cotsarelis G. Biology of hair follicles. <em>N Engl J Med.<\/em> 1999.<\/li>\n\n\n\n<li>Del Valle DM et al. Cytokine signatures in COVID-19. <em>Nat Med.<\/em> 2020.<\/li>\n\n\n\n<li>Ackermann M et al. Pulmonary vascular injury in COVID-19. <em>N Engl J Med.<\/em> 2020.<\/li>\n\n\n\n<li>Semenza GL. Hypoxia-inducible factors. <em>Cell.<\/em> 2012.<\/li>\n\n\n\n<li>Li Y et al. Hair follicle immune privilege. <em>J Invest Dermatol.<\/em> 2019.<\/li>\n\n\n\n<li>Mieczkowska K et al. Hair loss in COVID-19 patients. <em>J Am Acad Dermatol.<\/em> 2021.<\/li>\n\n\n\n<li>Starace M et al. Post-COVID telogen effluvium. <em>Dermatol Ther.<\/em> 2020.<\/li>\n\n\n\n<li>Rossi A et al. Telogen effluvium mechanisms in SARS-CoV-2. <em>Skin Appendage Disord.<\/em> 2021.<\/li>\n\n\n\n<li>Gupta AK et al. COVID-19 dermatologic manifestations. <em>J Eur Acad Dermatol Venereol.<\/em> 2021.<\/li>\n\n\n\n<li>Rebora A. Telogen effluvium. <em>Dermatology.<\/em> 2010.<\/li>\n\n\n\n<li>Sinclair R. Diffuse alopecia mechanisms. <em>Australas J Dermatol.<\/em> 2015.<\/li>\n\n\n\n<li>Tobin DJ. Hair follicle immunology. <em>Exp Dermatol.<\/em> 2017.<\/li>\n\n\n\n<li>Stenn KS, Paus R. Hair cycle regulation. <em>Physiol Rev.<\/em> 2001.<\/li>\n\n\n\n<li>Messenger AG. Hair disorders. <em>Clin Dermatol.<\/em> 2013.<\/li>\n\n\n\n<li>Wollina U. COVID-19 dermatology. <em>Clin Dermatol.<\/em> 2020.<\/li>\n\n\n\n<li>Recalcati S. Skin manifestations of COVID-19. <em>J Eur Acad Dermatol Venereol.<\/em> 2020.<\/li>\n\n\n\n<li>Fabbrocini G et al. Hair disorders review. <em>Dermatol Clin.<\/em> 2019.<\/li>\n\n\n\n<li>Daneshgaran G et al. Dermatologic COVID-19 effects. <em>Dermatol Ther.<\/em> 2020.<\/li>\n\n\n\n<li>Huang C et al. Clinical features of COVID-19. <em>Lancet.<\/em> 2020.<\/li>\n\n\n\n<li>Wu Z et al. COVID-19 epidemiology. <em>Lancet.<\/em> 2020.<\/li>\n\n\n\n<li>Guan WJ et al. Clinical characteristics of COVID-19. <em>N Engl J Med.<\/em> 2020.<\/li>\n\n\n\n<li>Zhou F et al. Mortality predictors in COVID-19. <em>Lancet.<\/em> 2020.<\/li>\n\n\n\n<li>Mehta P et al. Cytokine storm syndrome. <em>Lancet.<\/em> 2020.<\/li>\n\n\n\n<li>Nalbandian A et al. Post-acute COVID-19 syndrome. <em>Nat Med.<\/em> 2021.<\/li>\n\n\n\n<li>Davis HE et al. Long COVID symptoms. <em>eClinicalMedicine.<\/em> 2021.<\/li>\n\n\n\n<li>Taquet M et al. Neurological outcomes. <em>Lancet Psychiatry.<\/em> 2021.<\/li>\n\n\n\n<li>Crook H et al. Long COVID mechanisms. <em>BMJ.<\/em> 2021.<\/li>\n\n\n\n<li>Varga Z et al. Endotheliitis in COVID-19. <em>Lancet.<\/em> 2020.<\/li>\n\n\n\n<li>Tobin MJ. Silent hypoxia. <em>Am J Respir Crit Care Med.<\/em> 2020.<\/li>\n\n\n\n<li>Cotsarelis G. Hair follicle stem cells. <em>Science.<\/em> 1990.<\/li>\n\n\n\n<li>Wnt signaling in hair biology. <em>Nature.<\/em> 2015.<\/li>\n\n\n\n<li>HIF-1\u03b1 regulation studies. <em>Cell.<\/em> 2012.<\/li>\n\n\n\n<li>Tr\u00fceb RM. Stress and hair loss. <em>Exp Dermatol.<\/em> 2009.<\/li>\n\n\n\n<li>Sperling LC. Alopecia diagnostics. <em>J Am Acad Dermatol.<\/em> 2000.<\/li>\n\n\n\n<li>Gupta M et al. COVID-19 hair loss. <em>J Am Acad Dermatol.<\/em> 2021.<\/li>\n\n\n\n<li>Starace M et al. TE after COVID-19. <em>Dermatol Ther.<\/em> 2020.<\/li>\n\n\n\n<li>Elmas OF et al. Post-COVID alopecia. <em>Dermatol Ther.<\/em> 2021.<\/li>\n\n\n\n<li>Daneshgaran G et al. Cutaneous COVID-19. <em>Dermatol Ther.<\/em> 2020.<\/li>\n\n\n\n<li>Wollina U et al. COVID skin disease. <em>J Clin Med.<\/em> 2021.<\/li>\n\n\n\n<li>Rossi A et al. Hair follicle cycling in infection. <em>Skin Appendage Disord.<\/em> 2021.<\/li>\n\n\n\n<li>Fabbrocini G et al. Dermatology in systemic disease. <em>Dermatol Clin.<\/em> 2019.<\/li>\n\n\n\n<li>Messenger AG et al. Hair biology. <em>Clin Dermatol.<\/em> 2013.<\/li>\n\n\n\n<li>Sinclair R et al. Alopecia patterns. <em>Australas J Dermatol.<\/em> 2015.<\/li>\n\n\n\n<li>Paus R et al. Hair cycle control. <em>Physiol Rev.<\/em> 2001.<\/li>\n\n\n\n<li>Li Y et al. Immune privilege collapse. <em>J Invest Dermatol.<\/em> 2019.<\/li>\n\n\n\n<li>Semmler BE et al. Immune response in COVID-19. <em>Clin Immunol.<\/em> 2021.<\/li>\n\n\n\n<li>Ackermann M et al. Vascular pathology. <em>N Engl J Med.<\/em> 2020.<\/li>\n\n\n\n<li>Semenza GL et al. Hypoxia biology. <em>Cell.<\/em> 2012.<\/li>\n\n\n\n<li>Nalbandian A et al. Long COVID review. <em>Nat Med.<\/em> 2021.<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Comprehensive Review of Etiology, Physiology, Pathology, Proteomics, and Therapeutic Approaches 1. Abstract COVID-19, caused by SARS-CoV-2, is associated with a broad spectrum of post-infectious dermatologic sequelae, most prominently diffuse [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":14912,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[821,466,533],"tags":[],"class_list":["post-14881","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hair-loss-skin-dermatology","category-protein-fold-stability","category-skin-dermatology"],"_links":{"self":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/14881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=14881"}],"version-history":[{"count":4,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/14881\/revisions"}],"predecessor-version":[{"id":14885,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/14881\/revisions\/14885"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/media\/14912"}],"wp:attachment":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=14881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=14881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=14881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}